Metastatic leydig cell tumor of the testis report of three cases and review of the literature

Jean L. Grem, H. Ian Robins, Kenneth S. Wilson, Kennedy Gilchrist, Donald L. Trump

Research output: Contribution to journalArticle

85 Scopus citations

Abstract

Metastatic Leydig cell carcinomas account for less than 0.2% of all testicular cancers, and may be associated with sex hormone production. Leydig cell carcinoma is relatively refractory to radiotherapy and chemotherapy, and median survival of patients with metastatic disease is less than 2 years. Presented are three cases of metastatic Leydig cell cancer, and a review of the literature pertaining to this rare tumor.

Original languageEnglish (US)
Pages (from-to)2116-2119
Number of pages4
JournalCancer
Volume58
Issue number9
DOIs
StatePublished - Nov 1 1986

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Metastatic leydig cell tumor of the testis report of three cases and review of the literature. / Grem, Jean L.; Robins, H. Ian; Wilson, Kenneth S.; Gilchrist, Kennedy; Trump, Donald L.

In: Cancer, Vol. 58, No. 9, 01.11.1986, p. 2116-2119.

Research output: Contribution to journalArticle